2nd Quarter - Report

PRIME THERAPEUTICS for PRIME THERAPEUTICS

Firm
Client
Income
—
Expenses
$50,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

S. 778: Prescription Drug Monitoring Act - issues related to dispensers access to PDMPs across state lines.

LobbyistCovered position, as disclosed
JULIE CAROL CANTOR-WEINBERG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 778 (115th)

Health Issues HCR

H.R.749: "Lower Drugs Costs Through Competition Act,"--increasing generic competition. Legislation to address abuses of the REMS program to allow generic drugs to come to market faster.H.R.2212/S.974: CREATES Act--provisions related to removing barriers to generic competition.H.R.2430/S.934: FDA Reauthorization Act of 2017--provisions to ensure greater market competition for generics & biosimilars. S.469/H.R. 1245: Affordable and Safe Prescription Drug Importation Act--issues relating to noninterference and workability. H.R.1939/S.1044: Ensuring Seniors Access to Local Pharmacies Act of 2017 (any willing pharmacy bill)--provisions limiting payers' ability to selectively contract. Use of prescription drug coupons in federal programs and the ACA exchanges and their effects on insurance premiums. H.R.1628: The American Health Care Act of 2017 and The Better Care Reconciliation Act--provisions related to the stability of the exchanges. H.R.1316: The Prescription Drug Price Transparency Act--issues related to ensuring the continuity of MAC pricing. S.771/H.R.1776: Improving Access to Affordable Prescription Drugs Act--issues related to ensuring a competitive marketplace for prescription drugs. H.R.1703: Medical Product Communications Act of 2017--provisions relating to greater market access for off-label indications. S.778 Prescription Drug Monitoring Act--issues related to dispensers access to PDMP data across state lines. H.R.2026: Pharmaceutical Information Exchange Act--provisions relating to payer access to pharma data. H.R.2051: The FAST Generics Act--provisions that expedite market access for generics.

LobbyistCovered position, as disclosed
JULIE CAROL CANTOR-WEINBERG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1776 (115th), H.R. 1245 (115th), H.R. 1628 (115th), S. 469 (115th), S. 778 (115th), S. 1044 (115th), H.R. 2051 (115th), H.R. 2212 (115th), H.R. 1939 (115th), S. 974 (115th), H.R. 749 (115th), H.R. 2026 (115th), S. 934 (115th), H.R. 1703 (115th), H.R. 2430 (115th), H.R. 1316 (115th), S. 771 (115th)

Medicare/Medicaid MMM

H.R.413/H.R.1038: Improving Transparency and Accuracy in Medicare Part D Spending Act--provisions restricting payer quality payment programs in Medicare Part D. Draft bill to amend title XVIII of the Social Security Act to provide for greater access to drug cost information for Medicare beneficiaries by preventing cash price disclosure restrictions under Medicare prescription drug plan contracts with pharmacies--issues related to Medicare non-interference. S.469/H.R.1245: Affordable and Safe Prescription Drug Importation Act--issues relating to noninterference and workability. S.771/H.R.1776: Improving Access to Affordable Prescription Drugs Act--issues related to ensuring a competitive marketplace for prescription drugs. H.R.1939/S.1044, Ensuring Seniors Access to Local Pharmacies Act of 2017 (any willing pharmacy bill)--provisions limiting payers' ability to selectively contract. Use of prescription drug coupons in federal programs and the ACA exchanges and their effects on insurance premiums. S. 1003: To amend title XIX of the Social Security Act to add standards for drug compendia for physician use for purposes of Medicaid payment for certain drugs, and for other purposes. Provisions related do drug coverage in Medicare and Medicaid. H.R.1316: The Prescription Drug Price Transparency Act -Issues related to ensuring the continuity of MAC pricing. S.637: Creating Transparency to Have Drug Rebates Unlocked (C-Thru) Act--issues relating to Medicare Part D cash price disclosure. H.R.1628: The American Health Care Act of 2017 and The Better Care Reconciliation Act--Provisions related to the stability of the exchanges. Draft bill to amend part A of title XVIII of the Social Security Act to provider greater access to information regarding the items and services furnished to the individual under parts A and B of the Medicare program and greater context regarding the medication regimen of the individual, issues relating to use of Medicare data.

LobbyistCovered position, as disclosed
JULIE CAROL CANTOR-WEINBERG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1939 (115th), S. 771 (115th), H.R. 413 (115th), H.R. 1316 (115th), H.R. 1038 (115th), H.R. 1628 (115th), S. 469 (115th), H.R. 1245 (115th), H.R. 1776 (115th), S. 1044 (115th), S. 1003 (115th), S. 637 (115th)

Pharmacy PHA

H.R.2430/S.934: FDA Reauthorization Act of 2017--provisions to ensure greater market competition for generics & biosimilars. S.469/H.R.1245: Affordable and Safe Prescription Drug Importation Act --issues relating to noninterference and workability. S.778: Prescription Drug Monitoring Act--issues related to dispensers access to PDMP data across state lines. S.771/H.R.1776: Improving Access to Affordable Prescription Drugs Act--issues related to ensuring a competitive marketplace for prescription drugs. H.R.1939/S.1044: Ensuring Seniors Access to Local Pharmacies Act of 2017 (any willing pharmacy bill)--Provisions limiting payers' ability to selectively contract. Use of prescription drug coupons in federal programs and the ACA exchanges and their effects on insurance premiums. S.1003: To amend title XIX of the Social Security Act to add standards for drug compendia for physician use for purposes of Medicaid payment for certain drugs, and for other purposes; provisions related do drug coverage in Medicare and Medicaid. H.R.1703: Medical Product Communications Act of 2017--provisions relating to greater market access for off-label indications.

LobbyistCovered position, as disclosed
JULIE CAROL CANTOR-WEINBERG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 778 (115th), H.R. 1939 (115th), S. 771 (115th), S. 934 (115th), H.R. 1703 (115th), S. 1044 (115th), S. 469 (115th), S. 1003 (115th), H.R. 2430 (115th), H.R. 1245 (115th), H.R. 1776 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.